Joint Corp(JYNT) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 28 at 4:00 PM ET (Korea 10/29 05:00)
Full metrics table
| Index | - | P/E | 27.83 | EPS (ttm) | 0.26 | Insider Own | 16.23% | Shs Outstand | 14.2M | Perf Week | 1.26% |
| Market Cap | 0.10B | Forward P/E | 18.46 | EPS next Y | 63.89% | Insider Trans | 5.89% | Shs Float | 11.8M | Perf Month | -6.32% |
| Enterprise Value | 0.08B | PEG | - | EPS next Q | 0.08 | Inst Own | 68.79% | Short Float | 2.95% | Perf Quarter | -13.26% |
| Income | 0.00B | P/S | 1.75 | EPS this Y | 1300% | Inst Trans | -7.03% | Short Ratio | 4.61 | Perf Half Y | -18.06% |
| Sales | 0.06B | P/B | 6.5 | EPS next 5Y | - | ROA | 3.33% | Short Interest | 0.35M | Perf YTD | -16.74% |
| Book/sh | 1.12 | P/C | 4.46 | EPS past 3/5Y | 64.32% -26.62% | ROE | 10.64% | 52W High | -31.96% ($10.67) | Perf Year | -12.53% |
| Cash/sh | 1.63 | P/FCF | 24.27 | Sales past 3/5Y | -18.46% -1.33% | ROIC | 21.65% | 52W Low | 6.92% ($6.79) | Perf 3Y | -7.98% |
| Dividend Est. | - | EV/EBITDA | 15.45 | EPS Y/Y TTM | 285.78% | Gross Margin | 78.82% | Volatility(W/M) | 2.25% 3.41% | Perf 5Y | -91.47% |
| Dividend TTM | - | EV/Sales | 1.4 | Sales Y/Y TTM | -17.84% | Oper. Margin | 6.1% | ATR (14) | 0.23 | Perf 10Y | 182.49% |
| Dividend Ex-Date | - | Quick Ratio | 1.79 | EPS Q/Q | 650.82% | Profit Margin | 6.49% | RSI (14) | 44.5 | Recom | 2.5 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.79 | Sales Q/Q | 14.41% | SMA20 | 1.45% ($7.16) | Beta | 1.16 | Target Price | $10 |
| Payout | - | Debt/Eq | 0.13 | Earnings | 2026/11/5 | SMA50 | -7.25% ($7.83) | Rel Volume | 0.48 | Prev Close | $7.22 |
| Employees | 330 | LT Debt/Eq | 0.11 | EPS/Sales Surpr. | -121.41% 4.18% | SMA200 | -15.76% ($8.62) | Avg Volume(3M) | 0.08M | Price | $7.26 |
| IPO | 2014/11/11 | Option/Short | Yes/Yes | Trades | 653 | Volume | 36,041 | Change | 0.62% |
🦴 The Joint Corp. (JYNT) is a U.S. healthcare company that operates chiropractic clinics under "The Joint Chiropractic" brand. It runs a membership- and subscription-based care model that lets patients walk in without an appointment or insurance, and it has grown into an ultra-small-footprint healthcare service company by expanding most of its locations through franchising.
Over the past 1 year, on the lower side
32% below its 1-year high.
Traded less than usual. That is 48% of its average volume.
Next earnings report: November 5
8 days to go.
JYNT makes money exceptionally well
Of every $100 in sales, $6.10 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +1300.0% this year.
Tap to view numbers
The price is about the industry average
Counting its debt, for $100 of yearly operating cash you would pay $1,545. Peers typically go for $1,288. Compared with its own 3-year average, it is 59% cheaper now.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
The outlook is positive
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -91.5%. The S&P 500 did +69% over the same period.
Tap to view numbers
No dividend
It reinvests profits in the business instead of paying dividends.
Ownership looks stable
Institutions hold 68.8%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #39 of 48 in the industry
Based on market cap of $103M.
FAQ
What kind of company is JYNT?
JYNT belongs to the Healthcare sector and operates in the Medical Care Facilities industry.
What is the market cap of JYNT?
The market cap of JYNT is approximately $103M, ranking 4,464 within its sector.
What is the P/E ratio of JYNT?
JYNT has a P/E ratio of approximately 27.8x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for JYNT?
JYNT has recorded a 52-week high of $10.67 and a low of $6.79.
